Oncology

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?

Discover the latest in pathology and laboratory medicine with this roundup of short news stories

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Targeting a pathway that promotes cancer immune evasion could prolong immunotherapy and reduce its side effects for liver cancer patients

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

The WHO’s Classification of Tumors series is entering its fifth edition – and many accessibility improvements make the latest Blue Books the best yet

Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer

A new imaging technique provides detailed views of tumor cells, allowing researchers to visualize the transition from precancerous to cancerous

The microbial diversity and species distribution of the cervix may help diagnosticians determine the patients at increased risk of cervical cancer.

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.